Dr. Lal PathLabs Limited (BOM:539524)
India · Delayed Price · Currency is INR 1,907.50
+29.10 (1.55%)
At close: Jul 31, 2026
Dr. Lal PathLabs Stock Forecast
Stock Price Forecast
According to 26 analysts polled by S&P Global, Dr. Lal PathLabs stock has a consensus rating of "Buy" and an average price target of ₹1,920. The average 1-year stock price forecast is 0.66% higher than the current stock price, while the lowest is ₹1,180 (-38.14%) and the highest is ₹2,195 (+15.07%).
Price Target: ₹1,920 (+0.66%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Dr. Lal PathLabs stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 13 | 13 | 17 | 17 | 17 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 2 | 3 | 2 | 1 | 1 | 1 |
| Sell | 2 | 2 | 2 | 1 | 1 | 1 |
| Strong Sell | 4 | 2 | 2 | 2 | 2 | 2 |
| Total | 25 | 25 | 24 | 26 | 26 | 26 |
Financial Forecast
Revenue This Year
32.01B
from 27.63B
Increased by 15.87%
Revenue Next Year
36.38B
from 32.01B
Increased by 13.64%
EPS This Year
37.24
from 30.40
Increased by 22.49%
EPS Next Year
43.32
from 37.24
Increased by 16.32%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.